LexDanaLexDanabeta
Inventor

Arani CHANDA

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07BGeneral methods of organic chemistry21%
C07DHeterocyclic compounds21%
Y02ATechnologies for adaptation to climate change14%
PatentTitleYear
12,251,386Salt form of a human histone methyltransferase EZH2 inhibitor202511,498,916Crystalline FGFR4 inhibitor compound and uses thereof202211,491,163Salt form of a human histone methyltransferase EZH2 inhibitor2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to EISAI R&D MAN CO LTD (3)· patent assignee history
2022–2025Patents assigned to EPIZYME INC (2)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EISAI R&D MAN CO LTD32022–2025
EPIZYME INC22022–2025
Locations
LocationPatentsSpan
US32022–2025